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ABSTRACT: Population studies carried out during the 1980s had shown that the Maltese 
population was characterized by high blood lead (PbB) levels. These high levels appeared to be a 
feature at all age groups including neonates. A number of environmental control measures had 
been initiated to attempt to decrease these PbB levels. The present study reviews PbB levels in 
pregnant women and newborns. It is shown that mean cord PbB levels decreased significantly in 
the last decade from a mean of 165.1 + 87.9 ug/I in 1985 to 89.79 + 31.23 ug/I in 1996. This decrease 
did not correlate with the increasing use of multimineral supplements which include the zinc cation 
said to be useful to counter the effects of chronic lead intoxication. Placental transfer of lead is also 
shown to follow closely maternal levels with a correlation coefficient of 0.81. In spite of the 
apparent decrease in PbB levels, about half of newborns stilI have levels which require preventive 
community measures. 
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Introduction 
A number of studies carried out throughout the 1980s 
have shown that the Maltese population, including 
newborns, are chronically exposed to lead in their 
environment and have been reported to have 
significantly higher blood lead (PbB) levels than those 
proposed by the European Community. In a population 
study carried out in 1981, the Maltese population sample 
(n = 538) appeared to have higher PbB levels than the 
reference values proposed by a directive of the European 
Community with a reported mean value of 307 ug/l 
(EEC: 200 ug/l) and a 98th percentile of 863 ug/l (EEC: 
350 ug/l). Under a rigid quality control programme 
(WHO-UNEP), these elevated levels were a feature of 
both the male and female population, with overall lower 
values for females!. The PbB levels in Malta were 
similar in both men and women suggesting that this was 
not an occupational hazard but a continuous 
environmental one. A follow-up study two years later 
reported a slight drop in the mean PbB levels, but still 
elevated at 243 ug Pb/12. Subsequent studies have 
persistently confirmed the high PbB levels in the various 
sections of the Maltese population including neonates3. 
Other studies have shown that PbB levels are elevated in 
Maltese children aged 7-9 years with a mean of 241.5 ug 
Pb/I in Malta and 194.4 ug Pb/l in GOZ04. The causes for 
this high PbB level in the Maltese population have still 
not been fully elucidated, but are partly related to the 
high traffic density of the Islands4. The objectives of the 
present study were to determine whether these high 
levels have been maintained in the pregnant and neonatal 
population after the introduction of community 
preventive measures, and to assess the placental transfer 
kinetics of the lead cation. 
Materials and methods 
Paired blood samples were collected during labour 
from the mother and from the maternal side of the 
umbilical cord. The specimens were collected at random 
from all deliveries occuring in one specific month at 
Karin Grech Hospital, excluding only cases of multiple 
births or bad perinatal outcome pregnancies. Thirty­
eight samples of paired blood samples were considered 
suitable for assessent. PbB levels were assayed by 
atomic absorption spectrophotometry, electrothermal 
atomization (AAS-ET A) using a modified Fernandez 
method5. The mother was interviewed regarding the 
mineral supplements she had been prescribed during her 
pregnancy. The cord blood [CB] assays were then 
compared to 76 similar criteria samples analysed in 
1985 3. Statistical analysis was performed using a 
software package which included the Student's Hest and 
single linear regression. 
Results 
The 1985 group was assessed to have a bimodal 
distribution of CB PbB levels with a "breaking" point 
around 200 ug/l3. The mean and s.d. CB PbB levels of 
the 1985 population were estimated as 165.1 ± 87.9 ug/l 
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(Table I). About two-thirds of these neonates had PbB 
levels greater than the Centres for Disease Control 
(CDC) recommendations of 100 ug/l6. Of these 31.6% 
of neonates had PbB values greater than 200 ug/l. In 
contrast, the 1996 CB PbB levels were significantly 
(p«O.OOI) lower at 89.79 ± 31.23 ug/l. No neonates in 
this group had PbB values greater than 200 ug/l (Table 
1). Despite the 45.6% PbB level decrease noted in the 
last decade (Figure 1), a large proportion of neonates in 
1996 (47.4%) still have values for which the CDC 
recommends community prevention acti vities (> 1 00 ug/l). 
Table 1: Cord-blood PbB values - 1985 and 1996 
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Figure 1 - Blood lead levels distribution: 1985 and 1996 
The reasons for this shift over the last decade have not 
been identified. It has been proposed that zinc 
administration can alleviate the toxic effects of lead in 
human subjects? The proportion of zinc-containing 
prescriptions during pregnancy has definitely increased 
87.8 ± 32.3 ug/l p>0.5). It thus appears that the 
increasing use of zinc supplementation in multimineral 
preparations has not contributed towards the decrease in 
blood lead levels during the last decade (Table 2). 
The mean and s.d. CB PbB levels in the 1996 
population was estimated as 89.8 ± 31.2 ug/l. These 
levels were similar to, but slightly lower than, the 
maternal PbB levels reported at 108.0 ± 40.2 ug/l. The 
differences between the maternal and cord blood levels 
were statistically significant (p<0.05). None of the 
women had levels greater than 200 ug/l, but 47.4% had 
PbB values in the 100-149 ug/l range, while a further 
10.0% had values in the 150-199 ug/l range. 
The mean CB:maternal ratio was estimated as 0.87 ± 
0.22. There appeared to be a close linear correlation 
between maternal and CB PbB levels with a correlation 
coefficient of 0.81 (Figure 2). The correlation 
coefficient for paired samples (n = 40) assayed in 1985 
was estimated as 0.79. This high linear correlation 
suggests that the transfer of the lead cation through the 
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Figure 2: Lead cation Placental transfer 
placenta is by simple passive diffusion, while the high 
CB:maternal ratio confirms that the lead cations cross 
the placenta rapidly and follow very closely the maternal 
PbB levels. The placental transfer of the lead cation did 
not, in any way, appear to be influenced by zinc 
supplementation since the cord-blood-:maternal ratio was 
similar in women receiving iron with/out zinc (Table 2). 
Discussion 
Trace elements are having an increasing impact on 
clinical and community medicine. Much remains to be 
discovered about their roles, metabolism, and how they 
in the last decade from 
about I % in 19878 to the 
present rate of about 
44.7%. However the 
mean maternal PbB 
levels in women 
receiving zinc 
supplementation was not 
statistically different to 
the levels obtained from 
women who did not 
. ­
receive ZinC 
supplements (114.9 ± 
43.4 vs 102.4 ± 37.5 ug/ 
I p>O.I). Similar 
results were obtained in 
the cord-blood PbB 
levels (92.2 ± 30.7 vs 
Table 2: Blood lead levels by mineral supplementation (1996 sample) 
Mineral 
supplemen­
tation 
TOTAL 
POPULATION 
without zinc 
with zinc 
Statistical 
Significance 
CB PbB levels mat. PbB maternal : fetal 
no. % ug/l levels ratio 
mean ± s.d. ug/l mean ± s.d. 
mean ± s.d. 
38 100.0 89.8 ± 31.2 108.0 ± 40.2 0.87 ± 0.22 
21 55.3 87.8 ± 32.3 102.4 ± 37.5 0.89 ± 0.22 
17 44.7 92.2 ± 30.7 114.9 ± 43.4 0.84 ± 0.23 
t test = 0.429 t test = 0.938 t test = 0.679 
p> 0.5 n.s. p > 0.1 n.s. p > 0.1 n.s. 
l 
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interact with other major and minor nutrients. Several 
studies have shown that lead passes freely through the 
placenta so that a significant correlation (r = 0.63 - 0.8) 
between maternal and umbilical CB PbB levels has been 
observed9.1O.11 . The present study confirms that lead 
passes freely across the placenta with a correlation 
coefficient of 0.79 - 0.81, similar to that previously 
reported in the literature. Lead competes for similar 
binding sites with zinc, a trace element which has been 
suggested to be essential for normal growth. Because of 
this competition, it has been proposed that zinc 
administration can alleviate the toxic effects of lead in 
human subjects7. There has been a significant increase 
of multimineral (including zinc) prescriptions during 
pregnancy over the last decade. In 1987, 90.6% of 
Maltese pregnant women were reported to have received 
haematological supplementation during their pregnancy. 
However only 1 % received supplementation which 
included the zinc cation8. In 1996, an overall 92.1 % of 
the women received haematological supplementation 
during their pregnancy, including 44.7% who received 
also zinc supplements. The present study has failed to 
confirm any therapeutic benefits towards decreasing PbB 
levels by the use of zinc supplements during pregnancy 
either in the mother or fetus. Furthermore zinc 
administration did not appear to affect placental transfer 
of the lead cation. Zinc levels in the form of zinc 
protoporphyrin (ZPP) have been shown to be higher in 
the Maltese population than in the Belgian studied 
popUlation, statistically (p<0.007) correlating to PbB 
levels with a correlation coefficient of 0.48 1. 
The establishment in the 1980s that the Maltese 
popUlation had very high PbB levels resulted in a 
community drive to decrease the introduction of lead in 
the environment. This educational and legislative drive 
was primarily aimed at controlling the importation of red 
lead paint, and diminishing the use of lead-treated wood 
as firewood in bakeries. Further efforts were made to 
promote the use of unleaded petrol and controlling the 
disposal of used engine oil as fuel in bakeries. It now 
appears that these preventive measures have had a 
satisfactory effect on the Maltese environment. This 
study confirms that there has been a definite lowering in 
PbB levels in women and newborns. This decrease in 
PbB levels does not appear to be related to changing 
prescription habits, and thus is more likely to be due to 
community preventive activities. In spite of the reported 
decrease, newborn PbB levels remain sufficiently 
elevated by CDC criteria6 to require continuing 
preventive measures. The availiable data show that 
females and children are more sensitive than males to the 
toxic effects of lead, and it has been suggested that for 
full protection, females require a lower health-based 
occupational exposure limit for PbB than males. It is 
thus suggested that females with blood lead level values 
over 100 ug/l should have careful follow-up. More than 
half the Maltese pregnant women assessed in 1996 fell 
within this range. The exact effects of chronic subtoxic 
lead exposure on the fetus has yet to be fully determined, 
but protection of the developing embryo from injury due 
to lead exposure is an important point to be considered. 
A recent study has shown that infants exposed in utero 
to lead levels greater than 100 ug/l lost 4 to 6 points on 
development tests6 . A further possible health risk could 
arise from mothers with high blood lead concentrations 
transferring lead to the suckling infants through breast 
milk, in addition to that already transported through the 
placenta. Maternal blood lead concentrations have been 
shown to increase during lactation possibly because the 
mineral is released from the skeleton during times of 
increased demand for calcium 12. A significant 
correlation between maternal blood and breast milk lead 
levels (r = 0.29, p < 0.01) has been demonstrated 11, 
while the 6-month PbB levels of breast-fed infants 
correlated very well (r = 0.42, P = 0.0(03) with the lead 
content of breast milk 13. 
Conclusion 
Mothers with PbB levels greater than 100 ug/l should 
be given educational and nutritional counselling and a 
detailed environmental history should be taken to 
identify any obvious sources or pathways of lead 
exposure. Newborns with blood lead levels greater than 
100 ug/l should be regularly screened every 3 to 4 
months with repeated blood lead tests, and later screened 
for possible medical and neural complications . Infants 
with confirmed PbB levels greater than 200 ug/l must 
receive medical and environmental follow-up 6. 
Acknowledgements are due to the technical staff 
of the Toxicology Unit who helped analyse the blood 
samples, and the midwifery staff of the Labour Ward 
who collected the specimens. 
References 
I. 	 Bruaux P, Claeys-Thoreau F, Ducoffre G, Lafontaine A. 
Grech A, Vassallo A. Exposure to lead and cadmium of 
the general population of Malta. Int Arch Occup Environ 
Health 1983; 53:119-125. 
2. 	 Bruaux P, Svartengren M. Assessment of human 
exposure to lead: Comparison between Belgium, Malta, 
Mexico and Sweden. UNEP/WHO: Stockholm 1985. 
3. 	 Savona-Ventura C, Sammut M, Ducoffre G, Claeys F. 
Chronic lead exposure and pregnancy. Int 1 Risk Safety 
Med 1994; 6:25-33. 
4. 	 Sammut M, Savona-Ventura C. Petrol lead in a small 
island community. Int 1 Risk Safety Med 1996; 9:33-40. 
5. 	 Fernandez FJ. Micromethod for lead determination in 
whole blood by atomic absorption with use of the 
graphite furnance . Clin Ch em 1975; 21:558-56l. 
6. 	 CDC (Centers for Disease Control). Preventing lead 
poisoning in young children: a statement by the Centers 
for Disease Control. CDC, Atlanta, October 1991. 
7. 	 WHO. Recommended health based limits in occupational 
exposure to heavy metals. WHO Tech Rep Ser 647, 
Geneva, 1980, p.36-80. 
8. 	 Savona-Ventura C, Grech ES. International co-operative 
study on drug use in pregnancy. Results from Malta. 
Maltese Medical Journal 1990; 2(2):7-11; and original 
study dala sheets. 
9. 	 Gershanik 11. Brooks GG. Little lA . Blood lead values in 
pregnant women and their offspring . Am 1 Obstet Gyecol 
1974; 119(4):508-511. 
\0. 	 Zarembski PM, Griffiths PD. Walker l, Goodall HB. 
Lead 	 in neonates and mothers. Clin Chem Acta 1983; 
134:35-49. 
Il. 	 Ong CN, Phoon WO, Law HY, Tye CY. Lim HH. 
Concentrations of lead in maternal blood, cord blood. and 
breast milk. Arch Dis Child 1985; 60:756-759. 
12. 	 Ryu lE. Ziegler EE. Foman SJ . Maternal lead exposure 
and blood lead concentration In infancy. 1 Pediatr 1978; 
93:476-478. 
13. 	 Rabinowitz M, Leviton A, Needleman H. Lead in milk 
and infant blood: a dose-response model. Arch Environm 
Hlth 1985 : 40(5):283-286. 
The copyright of this article belongs to the Editorial Board of the Malta Medical Journal. The Malta 
Medical Journal’s rights in respect of this work are as defined by the Copyright Act (Chapter 415) of 
the Laws of Malta or as modified by any successive legislation. 
Users may access this full-text article and can make use of the information contained in accordance 
with the Copyright Act provided that the author must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the prior permission of the copyright 
holder. 
This article has been reproduced with the authorization of the editor of the Malta Medical Journal 
(Ref. No 000001) 
 
